Pharmaceuticals
News Releases
2012
December
November
Nutraceuticals
Official Sponsor of Osaka Marathon for Second Consecutive Year Otsuka Pharmaceutical Will Continue to Support Safe Running and Encourage Runners to Complete the Full Distance
Pharmaceuticals
Otsuka Pharmaceutical and Abdi İbrahim Established a Joint Venture Company for Pharmaceutical Sales in Turkey
Corporate
Otsuka Pharmaceutical Tokushima Itano Factory to Cosponsor Asan Walking Festival in Itano A Portion of Entry Fees to be Donated to Great East Japan Earthquake Relief Efforts
Pharmaceuticals
Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial
October
Nutraceuticals
Kenja no Shokutaku Double Support Food for Specified Health Use with Dual Function Suppressing the Absorption of Both Sugars and Lipids, to Launch in Japan for the First Time
Nutraceuticals
Super Vitamin D, Containing the Daily Optimum Dose of Vitamin D in One Single Tablet Launched from Nature Made® - America's Number One Dietary Supplement Brand
September
Nutraceuticals
New "Poppy Seed & Lemon" from Gerblé to launch on October 15 The No.1 French Health Food Brand now in 3,000 stores nationwide
Pharmaceuticals
Kyowa Hakko Kirin Returns to Otsuka Pharmaceutical the Rights to Develop and Market Busulfex®, for Use As a Part of Conditioning Regimen Prior to Hematopoietic Progenitor Cell Transplantation, in Japan and in Asian Countries & Regions
Pharmaceuticals
ABILIFY® ,The First Antipsychotic Agent in Japan Applying for Adjunctive Treatment in Major Depressive Disorder
August
Corporate
Otsuka, the First Pharmaceutical Company in Japan to Have Been Certified for "ISO22301", the International Standard for Business Continuity Management
Pharmaceuticals
Vasopressin V2-Receptor Antagonist, Samsca® Tablets Were Filed Additional Indication of the Treatment of Fluid Retention Associated with Cirrhosis of the Liver
Nutraceuticals
Pocari Sweat Launches in Vietnam through New Joint Venture Company. Vietnam Launch is the17th Market in the World Where the Pocari Sweat is Sold
July
Corporate
Otsuka Pharmaceutical × Nakacho, Tokushima Prefecture Largest Free Live Music Concert in Japan to Be Held
Pharmaceuticals
Acucela and Otsuka Pharmaceutical Announce the Initiation of a Phase 3 Clinical Trial to Evaluate Rebamipide Ophthalmic Suspension in Patients with Dry Eye Syndrome
Nutraceuticals
Otsuka Pharmaceutical To Boost Production Capacity and Increase Sales with Third Pocari Sweat Plant in Guandong Province,China
Pharmaceuticals
Proteus Digital Health, Inc. and Otsuka Pharmaceutical Co., Ltd. Announce Worldwide Agreement to Develop Novel Digital Health Products
June
Pharmaceuticals
Otsuka Pharmaceutical and Kyowa Hakko Kirin announce strategic alliance in the fields of diabetes and oncology
Corporate
Reverse Daylight Savings Program to Shift Peak Energy Consumption
Pharmaceuticals
UCB Japan Files for Indication of Pediatric Epilepsy (Partial Onset Seizures) for E Keppra® Tablet; New Dry Syrup Formulation Filed at the Same Time
Nutraceuticals
Otsuka Pharmaceutical to Participate as Core Partner in TEDxTokyo 2012 to Connect Innovative Ideas to the Future
Pharmaceuticals
The New England Journal of Medicine Publishes Efficacy Results of Otsuka's Delamanid for Multidrug-Resistant Tuberculosis New Research Shows 53% Increase in Sputum Culture Conversion (SCC) After Two Months
May
Pharmaceuticals
The Federal Circuit Decision Affirming the Validity of the Asserted Claims of Otsuka's Patent to ABILIFY®
Pharmaceuticals
Results from a Phase 3 Study of Once-monthly Aripiprazole Intramuscular (IM) Depot Formulation for the Maintenance Treatment of Schizophrenia Presented at APA Annual Meeting
March
Nutraceuticals
Gérlinéa to Launch Nationwide −Enjoyable Calorie Control without Giving Up Sweetness−
Nutraceuticals
Breaking Conventional Rules of Snack Foods Healthy and Innovative Soy Snack "SoyCarat" Debuts
Corporate
Otsuka America Announces Personnel Changes (PDF: 182.2 KB)
Nutraceuticals
Otsuka Pharmaceutical Releases its UL・OS Brand of Men's Cosmetics in South Korea First overseas market for the brand after it was launched in Japan three and a half years ago
February
Nutraceuticals
Otsuka Pharmaceutical Supports the Tokyo Marathon for Six Years Running with Amino-Value Supporting the efforts of over 200,000 runners
Corporate
Heartful Kawauchi Co., Ltd., A Promoter of Employment for Persons with Disabilities, Receives Authorization as Special Subsidiary Company
Corporate
Otsuka Pharmaceutical's Fukuroi Factory Receives FY2011 METI Minister Award for Factories Making an Outstanding Contribution to the Environment
January
Pharmaceuticals
Antipsychotic Agent ABILIFY® Receives Regulatory Approvals for Additional Indication "Improvement of Manic Symptoms Associated with Bipolar Disorder" and for New Dosage Form "ABILIFY® OD Tablets"
Pharmaceuticals
Otsuka Pharmaceutical Files New Drug Application for The Dopamine Agonist Transdermal Patch, Rotigotine Patch, in Japan
Pharmaceuticals
Otsuka Pharmaceutical and UCB focus collaboration in the area of Central Nervous System (CNS) disorders
Pharmaceuticals